It is not designed for that purpose, and positioning it as a weight loss peptide would be clinically inaccurate
Key Takeaways Two Active Ingredients, Five Products GLP-1 Market Represents a Financialized Business Model Prolonged Patent Protection & Market Exclusivity Two Active Ingredients, Five Products: Semaglutide is marketed by Novo Nordisk as three separate drug products under the brand names: Ozempic (injection for diabetes, approved in 2017), Rybelsus (oral tablet for diabetes, approved in 2019), and Wegovy (injection for weight loss, approved in 2021)
So the things to watch arent more weight-loss headlines, and Ill keep logging them in the GLP-1 pipeline tracker
Longitudinal study of moderate weight change and sleep-disordered breathing
Even when I was mindful of what I ate, I always felt hungry, and every year I kept gaining more and more weight